Maxigen Biotech Inc. (TPE:1783)
Taiwan · Delayed Price · Currency is TWD 39.40
-0.30 (-0.76%)
At close: May 8, 2026
Maxigen Biotech Market Cap
Maxigen Biotech has a market cap or net worth of 3.53 billion as of May 8, 2026.
Market Cap
3.53B
Enterprise Value
2.68B
Revenue
825.25M
Ranking
n/a
PE Ratio
13.04
Stock Price
39.40
Market Cap Chart
Since December 23, 2013, Maxigen Biotech's market cap has increased from 3.53B to 3.53B, an increase of 0.23%. That is a compound annual growth rate of 0.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.53B | -7.94% |
| Dec 31, 2025 | 3.84B | -12.06% |
| Dec 31, 2024 | 4.36B | 1.40% |
| Dec 29, 2023 | 4.30B | 6.65% |
| Dec 30, 2022 | 4.04B | 0.99% |
| Dec 30, 2021 | 4.00B | 151.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 8.03B |
| Formosa Optical Technology | 5.84B |
| Pacific Hospital Supply | 5.79B |
| St.Shine Optical | 5.17B |
| SciVision Biotech | 4.25B |
| Bionime | 3.96B |
| Nang Kuang Pharmaceutical | 3.42B |
| ICARES Medicus | 3.25B |